In Brief: In recent months, at least eight companies have been launched to develop RNA-modulating small molecules, and all have signed collaborations with big players
— which was developed by Raphael Townshend at Stanford and combines machine learning, wet-lab experimentation and 3D RNA structure modeling — to predict and identify parts of the transcriptome that are targetable with small molecules.
Anima’s platform combines phenotypic screening of live mRNA biology with AI to elucidate the mechanism of action of small-molecule mRNA drugs. Rgenta, which has a collaboration with Eli Lilly, is focused on finding oral medicines to tackle incurable diseases in oncology and neurology.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Protein structure prediction with in-cell photo-crosslinking mass spectrometry and deep learning - Nature BiotechnologyLimitations of Alphafold2 structure prediction are addressed by including experimentally determined distance constraints.
続きを読む »
Big crowd, big day for Bedard and the Pats in upset win over BladesConnor Bedard scored his 70th goal of the season and added an assist as the Pats upset the Blades 4-2 before a sold-out SaskTel Centre, capped at 14,768 fans.
続きを読む »
Phillies’ big bats bash Baltimore in latest sign of big season to comeRhys Hoskins continued his big spring with another home run and Nick Castellanos showed again how his offseason adjustments are paying off.
続きを読む »
Big changes — and a big chance at rebounding — are coming to SLC’s western gatewaySalt Lake City and private developers have big plans for the North Temple area.
続きを読む »
Component of RNA Found in Asteroid Ryugu SamplesSamples from the asteroid Ryugu collected by the Hayabusa2 mission contain nitrogenous organic compounds, including the nucleobase uracil, which is a part of RNA. Researchers have analyzed samples of asteroid Ryugu collected by the Japanese Space Agency’s Hayabusa2 spacecraft and found uracil—one
続きを読む »